Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Migraine Market is Expected to Expand at 6% Growth Rate by 2036, Owing to the Development of Novel Mechanisms beyond CGRP, including PACAP-targeted Therapies, TRPA1 Antagonists, and Next-generation Neuromuscular Approaches | DelveInsight

GlobeNewswire
The migraine market is expected to grow steadily over the forecast period (2026–2036) driven by the rising global prevalence of migraine, improving diagnosis rates, and increasing awareness of chronic and high-frequency migraine. In addition, the introduction of novel, differentiated therapies such as Elismetrep (Kallyope), Dysport (abobotulinumtoxinA; Ipsen), Xeomin (incobotulinumtoxinA; Merz Therapeutics GmbH), Bocunebart (AG09222; Lundbeck), EVO756 (Evommune), and others that move beyond traditional acute treatments is expected to further expand the market. The migraine market is expected to grow steadily over the forecast period (2026–2036) driven by the rising global prevalence of migraine, improving diagnosis rates, and increasing awareness of chronic and high-frequency migraine. In addition, the introduction of novel, differentiated therapies such as Elismetrep (Kallyope), Dysport (abobotulinumtoxinA; Ipsen), Xeomin (incobotulinumtoxinA; Merz Therapeutics GmbH), Bocunebart (AG09222; Lundbeck), EVO756 (Evommune), and others that move beyond traditional acute treatments is expected to further expand the market.
  1. EducationBolo Stick The Door Barricade WarrenBolo Stick Releases Free School Safety Checklist From a 33-Year Police VeteranBolo Stick founder Bill Barna built the printable checklist around five questions that cost nothing to answer. He says no single lock, action, or camera is the fail-safe to stop an attack, and each layer buys time and improves the odds of survival.
  2. Biotech & pharmaRobbins LLP Urges ARDX Stockholders to Contact the Firm for Information About the Securities Class Action Against Ardelyx, Inc.Ardelyx, Inc. faces allegations that it misled investors regarding the true state of its commercial performance and growth prospects of its two core drugs.
  3. Food & drinkOliveda International, Inc. (OLVI) Announces Christina Perri Performance at Olive Tree People Inc. Celebration of Revolutionary New Beauty Ecosystem at Venice Beach FestivalOlive Tree People celebrated the unveiling of its Olive Ecosystem at a Venice Beach festival with live music, food, olive tree-connected experiences, more.
  4. Logos Resmi Diluncurkan di Money20/20 USA untuk Membantu Lembaga Keuangan Membangun Bisnis Baru dengan Aset yang Ditokenisasi dan StablecoinDidirikan oleh Mantan Eksekutif Swift dan Matter Labs serta Didukung oleh ParaFi dan VanEck, Logos Meluncurkan Testnet dengan Paysend dan Securitize sebagai Mitra Desain Awal
  5. Logos เปิดตัวในงาน Money20/20 USA เพื่อช่วยให้สถาบันการเงินสร้างธุรกิจใหม่ด้วยสินทรัพย์แปลงเป็นโทเคนและสเตเบิลคอยน์ก่อตั้งโดยอดีตผู้บริหารจาก Swift และ Matter Labs พร้อมได้รับการสนับสนุนจาก ParaFi และ VanEck โดย Logos เปิดตัวเครือข่ายทดสอบ (Testnet) ร่วมกับพันธมิตรออกแบบเริ่มต้นอย่าง Paysend และ Securitize
  6. Robbins LLP Urges DOCS Stockholders to Contact the Firm for Information About the Class Action Against Doximity, Inc.Doximity, Inc. (DOCS) faces allegations that it failed to disclose to investors that it was losing market share to its competitors.